Загрузка страницы

FcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives

FcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives

Chair, Vera Bril, BSc, FRCPC, MD, Amy Clarke, MSN, RN, IgCN, Francesco Saccà, MD, and Kaitlin Stockwell Masters discuss myasthenia gravis in this CME/NCPD/CPE/IPCE activity titled “Leveraging FcRn Modulation in Personalized Management of Generalized Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives to Achieve Treatment Goals.” For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/EZC865. CME/NCPD/CPE/IPCE credit will be available until May 10, 2024.

Видео FcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives канала PeerView CME
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
10 мая 2023 г. 0:23:38
00:57:03
Другие видео канала
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into PracticeDrs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsnDrs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsnNon–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging TherapiesNon–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging TherapiesPCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in HyperlipidemiaPCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in HyperlipidemiaSevere Asthma: Directing New Treatment Approaches at the Airway EpitheliumSevere Asthma: Directing New Treatment Approaches at the Airway EpitheliumEpisode 5. State-of-the-Art Treatment: Catching Up With Current GuidelinesEpisode 5. State-of-the-Art Treatment: Catching Up With Current GuidelinesStrategies for Improving Outcomes in Hypertrophic CardiomyopathyStrategies for Improving Outcomes in Hypertrophic CardiomyopathyEpisode 4: How Can We Talk About VTE to Our Patients?Episode 4: How Can We Talk About VTE to Our Patients?Watch Drs. Bar-Or & Oh discuss #MultipleSclerosis updates from #CMSC - https://bit.ly/2024MSYWatch Drs. Bar-Or & Oh discuss #MultipleSclerosis updates from #CMSC - https://bit.ly/2024MSYThe Challenges of EoE: Diagnosis and Integrating Targeted Therapy Using a Team ApproachThe Challenges of EoE: Diagnosis and Integrating Targeted Therapy Using a Team ApproachDrs. Abou-Alfa, El-Khoueiry, Kaseb, & Stein discuss #HCC at #GI24 - https://bit.ly/HCCSF24YDrs. Abou-Alfa, El-Khoueiry, Kaseb, & Stein discuss #HCC at #GI24 - https://bit.ly/HCCSF24YOvercoming Challenges in the Management of Moderate to Severe ADOvercoming Challenges in the Management of Moderate to Severe ADLeveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis CareLeveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care#NCFBE updates from #ATS2024 led by Drs. Addrizzo-Harris & Rutland - https://bit.ly/NCFBE24SanDiegoY#NCFBE updates from #ATS2024 led by Drs. Addrizzo-Harris & Rutland - https://bit.ly/NCFBE24SanDiegoYNew Developments in Allergic and Inflammatory DiseasesNew Developments in Allergic and Inflammatory DiseasesIndividualizing Treatment With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DMIndividualizing Treatment With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DMHBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030Alzheimer’s Disease Case Conference: The Role of Neuroradiology in Diagnosis and TreatmentAlzheimer’s Disease Case Conference: The Role of Neuroradiology in Diagnosis and TreatmentClinical Utility of Mucus Plugging and Airway HyperresponsivenessClinical Utility of Mucus Plugging and Airway HyperresponsivenessEpisode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World StudiesEpisode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World Studies
Яндекс.Метрика